Such a bummer-they hired great reps to take them into the hospitals and the future...and then the gut the company? This is going to help sales? No, no it won't. It will hurt sales. Greatly. Shame; great products, great people and dominant...until J&J quickly destroyed them.
Some of these comments are pretty true... layoffs of 75, yes. JNJ screwing with culture, yes. Big companies move in the wrong direction from time to time, yes (JNJ now twice with Evolence and now the facial team here). I would agree with all of you that so far JNJ has not made very good decisions in the facial arena. Clearly it would be smarter to have a co-marketing agreement with Medicis or another blockbuster HA... but those decisions were not made.
The problems with these posts are that they are all short sighted. Maybe Mentor will get sold off, maybe not... but it is doubtful. But if one had any sense, they would of known not too flood the market with reps in a time like this, but clearly someone was drinking a bit too much at a board meeting when they made the colossal mistake of hiring a bunch of reps that had no actual market moving power with lackluster products to push.
Allergan is a good company, but unfortunately for them... their culture also produces average reps at best. They have the follow up skills of an attention deficit disorder child.
All the companies seem to look alike lately with the amount of unwanted government influence and lack of free enterprise thinking. It would nice to be able to run a for-profit company with a mentality of taking market share back, but we shall see what happens.
For now, this is still a great place to work... with a ton of great people. The excellent reps that left the company were replaced by mostly excellent reps. You tend to get some crappy hires, but it happens to everyone. Our competition is flooded with people that should have been laid off many moons ago. There will be another turn over soon, but I do not think it will be lay offs, but take offs. Think long term, cream always rises to the top.